Anti-Human IL1Beta Recombinant Antibody (Canakinumab) (CAT#: TAB-021)

Host: Human

Isotype: IgG1 - kappa

Applications: Suitable for use in FC, IP, ELISA, Neut, FuncS, IF, IHC and most other immunological methods.

• Tested Data
• Gene Expression
• Datasheet
• MSDS
• Publications
• COA

ELISA

Figure 1 Human IL1 Beta Therapeutic Antibody (TAB-021) in ELISA

ELISA analysis of TAB-021 was performed by coating with Recombinant Human IL1 Beta.

WB

Figure 2 Human IL1 Beta Therapeutic Antibody (TAB-021) in WB

Western blot analysis of TAB-021 was performed with Recombinant Human IL1 Beta.
Lane 1: Non-Reducing Antigen (1ug)
Lane 2: Reducing Antigen (1ug)

RNA Expression

Figure 1 RNA cell line category: Cell line enhanced (BJ hTERT+, HBEC3-KT, HMC-1, hTEC/SVTERT24-B, hTERT-RPE1, U-87 MG)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000125538-IL1B

Figure 1 RNA cell line category: Cell line enhanced (BJ hTERT+, HBEC3-KT, HMC-1, hTEC/SVTERT24-B, hTERT-RPE1, U-87 MG)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000125538-IL1B

 Datasheet

 MSDS

Peer-reviewed Publications

Our products have been used extensively by scientists all over the world to accelerate their life science research. Here, we present a collection of publications that cite this product.

Siu, Kam-Leung, et al. "Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC." The FASEB Journal (2019): fj-201802418R.

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Specifications

Product Property

Target

Related Resources

Rheumatoid Arthritis

Maturity Onset Diabetes of the Young

TNF Signaling Pathway

Product Notes

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Canakinumab"

Afuco™ Anti-IL1B ADCC Recombinant Antibody (Canakinumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Human IL1 beta. Canakinumab (INN, trade name Ilaris, previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.
Canakinumab was for the treatment of rheumatoid arthritis. Canakinumab is as a possible treatment for chronic obstructive pulmonary disease, gout and coronary artery disease.

See other products for "IL1B"

Customer Reviews and Q&As

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.